|
Name: Betamethadol
Type: Opioid analgesic
AKA: N/A
|
|
II. Natural Derivative
Synthetic substance, no natural derivative
 |
|
III. Chemical Profile (IUPAC name)
|
|
IV. History
Betamethadol, an opioid analgesic, was developed in the 1960s and is used for pain relief. It is part of opioid research and is known for its effectiveness in managing severe pain, although it has been overshadowed by other opioids with fewer side effects.
|
|
V. Legal Information
Betamethadol is an opioid analgesic with high abuse potential. It is controlled under opioid laws due to its addictive properties and risk of misuse. [Source: UNODC].
US Federal Schedule - I
Schedule I drugs, substances, or chemicals are defined as drugs with no currently accepted medical use and a high potential for abuse. Some examples of Schedule I drugs are: heroin, lysergic acid diethylamide (LSD), marijuana (cannabis), 3,4-methylenedioxymethamphetamine (ecstasy), methaqualone, and peyote.
Key US Federal Policies:
Controlled Substances Act. Public Law: Public Law 91-513 (text can be found on GovInfo) (https://www.dea.gov/drug-information/csa). Date enacted: October 27, 1970.
|
|
VI. Physical Effects
Betamethadol is an opioid analgesic used for pain relief. It causes sedation, respiratory depression, and constricted pupils. Short-term use provides effective pain management, while long-term use can lead to addiction and severe health issues. Overdose risks include respiratory depression and potential death. Safe use requires medical supervision. Recent research highlights its potency and associated risks with opioid use.  |
|
VII. Psychological Effects
Betamethadol, an opioid analgesic, provides pain relief and sedation. Immediate effects include euphoria and cognitive impairment. Long-term use can result in dependence, tolerance, and withdrawal symptoms. Chronic use is associated with mood disorders, cognitive decline, and high overdose risk. Recent research emphasizes its abuse potential and psychological risks similar to other opioids.
 |
|
VIII. Culture
Betamethadol, a synthetic opioid, was developed in the mid-20th century for pain management. Its cultural significance includes its role in opioid research and development. Proponents value its effectiveness in treating pain, while opponents focus on addiction risks and the broader opioid crisis. Its use is primarily medicinal, reflecting ongoing concerns about opioid treatment and safety.
 |